Got Stress Capsules

Calm Brain Support

Endocannabinoid System (ECS) Supplement

A targeted formulation designed to support the body’s natural response to stress by assisting signaling pathways connected to the Endocannabinoid System (ECS).
Got Stress Capsules combine cannabinoids, plant terpenes, and complementary botanical compounds using the ECS Therapy 3-Layer ECS Modulation System™ to support pathways associated with mood balance and nervous system regulation.

Multi-Pathway Stress Support

The ECS Therapy Got Stress Capsules formulation was developed to support biological pathways involved in the body’s stress response.
The formula combines cannabinoids, calming terpenes, botanical compounds, flavonoids, and nutritional cofactors to support signaling pathways connected to:
These ingredients work together using the ECS Therapy 3-Layer ECS Modulation System™, designed to support signaling pathways connected to the Endocannabinoid System (ECS).

Why the Endocannabinoid System Is Connected to Stress

The Endocannabinoid System (ECS) plays an important role in how the body responds to stress.
Scientists have found that the ECS helps regulate communication between the brain and body systems involved in emotional balance, nervous system signaling, and stress adaptation.
Research suggests that the ECS acts as a biological buffer for stress, helping the body maintain internal balance during challenging conditions.

Key Roles of the ECS in Stress Regulation

Scientific research has identified several mechanisms through which the ECS may influence the body’s stress response.

HPA Axis Regulation

The ECS helps regulate activity within the hypothalamic-pituitary-adrenal (HPA) axis, the system responsible for controlling the body’s stress hormone response.

Activation of CB1 receptors in the nervous system has been shown to influence the release of stress hormones such as cortisol.

Neurotransmitter Regulation

The ECS helps regulate the release of excitatory and inhibitory neurotransmitters in the brain.

This modulation may influence activity in stress-sensitive brain regions such as:

These areas play key roles in emotional processing and stress response.

Acute vs Ongoing Stress Response

During short-term stress events, levels of certain endocannabinoids may temporarily change.

However, the ECS is believed to help buffer the body’s response to ongoing stress, supporting the return toward biological balance once the stressor has passed.

Fear Memory and Behavioral Adaptation

Research suggests the ECS may also play a role in how the brain processes and adapts to stressful experiences.

Endocannabinoid signaling has been associated with the brain’s ability to extinguish fear memories, helping individuals adapt to safe environments following stressful events.

Stress Habituation

The ECS may also contribute to stress habituation, the process through which the body becomes less reactive to repeated stress exposure over time.

This process has been linked to signaling molecules such as 2-AG in brain regions associated with stress regulation.

When Stress Overwhelms the ECS

Research suggests that prolonged stress may disrupt normal ECS signaling.

Reduced endocannabinoid activity has been associated with altered stress regulation and may influence mood and emotional balance.

Supporting healthy ECS signaling has therefore become an area of growing scientific interest.

Formulated to Modulate

Because the Endocannabinoid System plays a central role in stress regulation, ECS Therapy developed Got Stress Capsules to support multiple signaling pathways connected to this system.


Rather than relying on a single compound, the formulation combines cannabinoids, calming terpenes, botanical compounds, flavonoids, and nutritional cofactors using the ECS Therapy 3-Layer ECS Modulation System™.


This layered formulation strategy is designed to support biological pathways associated with:

By supporting multiple pathways connected to the Endocannabinoid System, the formulation was designed to provide a broader approach to stress support than single ingredient supplements.

Total Cannabinoid Content

Per 2-Capsule Serving.
These cannabinoids are included to support signaling pathways associated with:

Complementary Calm Support Complex

(Proprietary Botanical & Nutritional Blend)

This formulation includes a combination of botanical compounds and nutritional cofactors
selected to support pathways associated with calmness and stress balance.

Exact ratios are maintained as part of the ECS Therapy proprietary formulation system developed through years of research and real-world field testing.

Calming Terpene Complex

(Proprietary Terpene Blend)

Plant terpenes are included to support signaling pathways connected to the
Endocannabinoid System and nervous system balance.

Includes:

Exact terpene ratios are maintained as part of the ECS Therapy proprietary terpene complex.

Suggested Use

Start Day 1 with 1 capsule in the morning with food.

If additional support is desired, increase to 2 capsules twice daily with food.

Capsule Information

This bottle may provide 30–60 days of use depending on individual needs.

Compliance Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Scientific References

Research discussing the role of the Endocannabinoid System in stress regulation has been published in peer-reviewed literature including:

ECS Therapy Philosophy

ECS Therapy formulations are developed using a layered formulation strategy designed to support multiple biological pathways connected to the Endocannabinoid System (ECS).

Our formulations combine:

Each formulation is refined through research, formulation development, and real-world field testing.

Scientific References

Research discussing the role of the Endocannabinoid System in stress regulation has been published in peer-reviewed literature including:

Explore the Science

Learn how ECS Therapy supplements support the Endocannabinoid System.
Scan to explore ECS science
(QR code → ECS pillar page)

The Scientists Who Made This Possible

Dr. Raphael Mechoulam

The Godfather of Cannabis Research Isolated and synthesized THC and CBD, fundamentally reshaping our understanding of cannabinoids and discovering the endocannabinoid system itself. Without Dr. Mechoulam’s foundational work, none of this would exist. When he responded to my email in May 2019 with his clinical trial data, he gave me the blueprint for what ECS modulation could be.

Dr. Ethan Russo

Demonstrated that terpenes and cannabinoids work synergistically, proving that “the sum of all the parts” is greater than isolated components. His 2016 paper “Beyond Cannabis: plants and the endocannabinoid system” expanded the conversation beyond a single plant—showing that the ECS is larger than cannabis alone. His research directly supports what we’re doing.

Dr. Sue Sisley

The Advocate for Real-World Science Conducted the first FDA-approved randomized controlled trial assessing the safety and efficacy of cannabis in military veterans with PTSD, fighting federal barriers to conduct rigorous clinical research on whole-plant medicine. Dr. Sisley’s persistence—filing lawsuits against the DEA, breaking the federal monopoly on cannabis research—proved that real-world cannabinoid research matters more than pharmaceutical shortcuts.

Dr. William Courtney

Pioneer of Raw Cannabinoid Research First to systematically study THCA, CBDA, and other raw cannabinoid precursors, demonstrating that cannabinoids in their natural (non-heated) form have therapeutic potential superior to decarboxylated forms at lower doses. His work expanded my understanding of the complete cannabinoid spectrum and why Phase 2 formulations will use raw cannabinoid compounds alongside decarboxylated forms.

Dr. Shimon Ben-Shabat

Co-Discoverer of the Entourage Effect Collaborated with Dr. Mechoulam in 1998 to propose the concept that compounds work better together than in isolation. This foundational principle—botanical synergy—is the entire philosophy behind ECS Therapy’s three-layer approach.

Dr. Dustin Sulak

Pioneer of Clinical Cannabinoid Medicine & Patient-Centered Education Founded Integr8 Health (serving 8,000+ patients with medical cannabis) and Healer.com, providing rigorous education on the endocannabinoid system and clinical cannabinoid protocols. His work bridges the gap between scientific research and real-world patient application. I studied his comprehensive courses on ECS science, cannabinoid dosing, and condition-specific treatment guidelines—education that became foundational to how I approach formulation and patient outcomes. Dr. Sulak’s emphasis on “using the correct dose” and understanding the ECS at every level directly informed ECS Therapy’s precision approach.